Bridging the gap between microbial limits and extremes in space: space microbial biotechnology in the next 15 years.


Journal

Microbial biotechnology
ISSN: 1751-7915
Titre abrégé: Microb Biotechnol
Pays: United States
ID NLM: 101316335

Informations de publication

Date de publication:
01 2022
Historique:
received: 05 09 2021
accepted: 05 09 2021
pubmed: 18 9 2021
medline: 28 1 2022
entrez: 17 9 2021
Statut: ppublish

Résumé

The establishment of a permanent human settlement in space is one of humanity's ambitions. To achieve this, microorganisms will be used to carry out many functions such as recycling, food and pharmaceutical production, mining and other processes. However, the physical and chemical extremes in all locations beyond Earth exceed known growth limits of microbial life. Making microbes more tolerant of a greater range of extraterrestrial extremes will not produce organisms that can grow in unmodified extraterrestrial environments since in many of them not even liquid water can exist. However, by narrowing the gap, the engineering demands on bioindustrial processes can be reduced and greater robustness can be incorporated into the biological component. I identify and describe these required microbial biotechnological modifications and speculate on long-term possibilities such as microbial biotechnology on Saturn's moon Titan to support a human presence in the outer Solar System and bioprocessing of asteroids. A challenge for space microbial biotechnology in the coming decades is to narrow the microbial gap by systemically identifying the genes required to do this and incorporating them into microbial systems that can be used to carry out bioindustrial processes of interest.

Identifiants

pubmed: 34534397
doi: 10.1111/1751-7915.13927
pmc: PMC8719799
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-41

Informations de copyright

© 2021 The Authors. Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd.

Références

Int J Syst Evol Microbiol. 2003 May;53(Pt 3):847-851
pubmed: 12807211
Mil Med Res. 2018 May 14;5(1):18
pubmed: 29807538
Appl Environ Microbiol. 2000 Apr;66(4):1680-4
pubmed: 10742260
Sci Adv. 2020 Sep 25;6(39):
pubmed: 32978156
Proc Natl Acad Sci U S A. 2015 May 12;112(19):6122-7
pubmed: 25918381
J Appl Microbiol. 2015 Jul;119(1):1-10
pubmed: 25809882
Nat Rev Microbiol. 2009 Mar;7(3):237-45
pubmed: 19172147
Astrobiology. 2012 Mar;12(3):258-70
pubmed: 22416764
Astrobiology. 2008 Oct;8(5):909-19
pubmed: 18950287
Environ Microbiol. 2007 Mar;9(3):801-13
pubmed: 17298378
DNA Repair (Amst). 2008 Mar 1;7(3):353-79
pubmed: 17951115
Astrobiology. 2012 Dec;12(12):1135-42
pubmed: 23140229
Front Microbiol. 2019 Apr 15;10:780
pubmed: 31037068
Microb Biotechnol. 2022 Jan;15(1):29-41
pubmed: 34534397
Life (Basel). 2014 May 26;4(2):250-66
pubmed: 25370197
Science. 2009 Jul 3;325(5936):64-7
pubmed: 19574385
Appl Microbiol Biotechnol. 2000 Sep;54(3):287-301
pubmed: 11030563
J R Soc Interface. 2015 Dec 6;12(113):20150803
pubmed: 26631337
Appl Biochem Biotechnol. 2008 Dec;151(2-3):686-99
pubmed: 18592407
Microbiol Mol Biol Rev. 2010 Mar;74(1):121-56
pubmed: 20197502
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14373-7
pubmed: 20660760
Appl Environ Microbiol. 2004 Jan;70(1):550-7
pubmed: 14711687
Biochim Biophys Acta. 2002 Mar 25;1595(1-2):367-81
pubmed: 11983409
Science. 2010 Oct 22;330(6003):463-8
pubmed: 20966242
Icarus. 2000 Aug;146(2):343-59
pubmed: 11543504
FEMS Microbiol Rev. 2016 Sep;40(5):722-37
pubmed: 27354346
J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):193-9
pubmed: 15471227
J Biotechnol. 1996 Jun 27;47(2-3):261-9
pubmed: 11536764
Sci Rep. 2019 Dec 5;9(1):18462
pubmed: 31804539
Adv Space Res. 1989;9(6):173-6
pubmed: 11537369
Trends Microbiol. 2010 Jul;18(7):308-14
pubmed: 20381355
Nat Commun. 2020 Nov 10;11(1):5523
pubmed: 33173035
BMC Microbiol. 2012 Sep 17;12:207
pubmed: 22985230
Appl Environ Microbiol. 2000 Sep;66(9):4142-4
pubmed: 10966444
Photochem Photobiol. 2001 Mar;73(3):249-56
pubmed: 11281021
Front Microbiol. 2015 Nov 05;6:1209
pubmed: 26594201
Trends Microbiol. 1999 Sep;7(9):362-5
pubmed: 10470044
Radiat Res. 2008 Jul;170(1):127-38
pubmed: 18582161
Nat Prod Rep. 2002 Jun;19(3):292-311
pubmed: 12137279
Front Microbiol. 2020 Oct 14;11:579156
pubmed: 33154740
Orig Life Evol Biosph. 2012 Oct;42(5):405-9
pubmed: 23065397
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10949-54
pubmed: 18664583
Adv Space Res. 1992;12(5):97-106
pubmed: 11537084
Life Support Biosph Sci. 1999;6(3):161-7
pubmed: 11542676
Trends Biotechnol. 2009 Dec;27(12):664-72
pubmed: 19793618
Res Microbiol. 1994 Feb;145(2):111-20
pubmed: 8090991
Appl Environ Microbiol. 1995 Oct;61(10):3592-7
pubmed: 7486995
Appl Microbiol Biotechnol. 1999 Feb;51(2):229-34
pubmed: 10091330
Icarus. 1990;85:241-56
pubmed: 11538367
Saline Syst. 2008 Sep 15;4:14
pubmed: 18793408
Science. 2014 Jan 24;343(6169):1244797
pubmed: 24324275
Trends Biotechnol. 2000 Jan;18(1):26-31
pubmed: 10631778
Biochem Soc Trans. 2016 Aug 15;44(4):1158-64
pubmed: 27528764
BMC Microbiol. 2021 Jan 6;21(1):9
pubmed: 33407113
Appl Environ Microbiol. 2000 Apr;66(4):1489-92
pubmed: 10742231
Biotechnol J. 2017 Oct;12(10):
pubmed: 28857502
Appl Environ Microbiol. 2010 Nov;76(22):7559-65
pubmed: 20889789
PLoS One. 2013 Dec 04;8(12):e80677
pubmed: 24324620
Radiat Res. 2016 Apr;185(4):349-58
pubmed: 27018778
Science. 2004 Nov 5;306(5698):1025-8
pubmed: 15459345
Appl Environ Microbiol. 2006 Feb;72(2):1218-25
pubmed: 16461669
Sci Rep. 2018 Oct 8;8(1):14938
pubmed: 30297913
Front Microbiol. 2015 Apr 10;6:284
pubmed: 25914687
Science. 2006 Apr 21;312(5772):400-4
pubmed: 16627738

Auteurs

Charles S Cockell (CS)

UK Centre for Astrobiology, School of Physics and Astronomy, University of Edinburgh, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH